Table 1 Clinical characteristics of the patients
Clinical information | Number (%) | |
|---|---|---|
Age at diagnosis | Mean | 61.6 |
Median | 64 | |
<60 years | 67 (38.7) | |
>60 years | 106 (61.3) | |
Gender | Female | 79 (45.7) |
Male | 94 (54.3) | |
Localisation | Nodal only | 79 (45.7) |
Extranodal only | 61 (35.3) | |
Nodal and extranodal | 30 (17.3) | |
No data available | 3 (1.7) | |
Stage | I | 26 (15.0) |
II | 21 (12.1) | |
III | 16 (9.2) | |
IV | 16 (9.2) | |
No data available | 94 (54.3) | |
Chemotherapy | CHOP-like regimen | 72 (92.5) |
Intensive regimen | 2 (1.2) | |
VACOP | 3 (1.7) | |
Low-intensity regimen | 6 (3.5) | |
No treatment | 2 (1.2) | |
Rituximab | Yes | 49 (28.3) |
No | 43 (24.9) | |
No data available | 81 (46.8) | |
Rituximab (patients with CHOP-like regimen) | Yes | 45 (26.0) |
No | 27 (15.6) | |
No data available | 101 (58.4) | |
Radiotherapy | Yes | 24 (13.9) |
No | 59 (34.1) | |
No data available | 90 (52) | |
Response to treatment | Complete remission | 49 (28.3) |
Recurrence | 47 (27.2) | |
Death without disease-free interval | 41 (23.7) | |
Loss of follow-up | 36 (20.8) |